Business JB Pharma records revenue growth of 36% to INR 809 crores in Q2 FY23Hindustan SagaNovember 12, 2022 by Hindustan SagaNovember 12, 20220184 Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra), [India]: JB Pharma, one of the fastest growing pharmaceutical companies in India continued on... Read more
